The global warfarin market is expected to witness steady growth through 2031, driven by the increasing prevalence of cardiovascular diseases and the continued demand for cost-effective anticoagulant therapies. According to The Insight Partners, the market is projected to grow at a CAGR of 3.7% during 2025–2031, reflecting sustained adoption across both developed and emerging healthcare...